PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1190727
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1190727
The electrosurgical generators market is expected to register a CAGR of 6.9% over the forecast period.
Although COVID-19 was not a surgical disease, it considerably impacted surgical practice. A surgical plume is a by-product of energy devices, including electrosurgical instruments, that creates thermal tissue damage. The structure and stability of the virus, the possible dose to which operating room staff exposed it, and the temperature at which the electrosurgical device produced the smoke were a few factors that affected the infectiousness of viral particles discovered in the surgical plume. Such instances significantly restricted the use of electrosurgical generators in surgical operations amid the outbreak.
However, the introduction of newer guidelines for safety under minimally invasive surgery (MIS), like electrosurgical procedures, was undertaken in the years 2021 and 2022, impacting the market's growth positively. As per the report published by the Journal of Surgical Endoscopy in March 2022, for every open procedure, precautions were taken to keep the operating room staff from being exposed to the surgical plume, which may include viruses. Hence, the safety precautions for surgical plumes during electrosurgical procedures helped physicians and patients perform the surgery with minimal exposure to COVID-19. Such factors have contributed to the market's growth in the post-pandemic phase. Furthermore, as per the analysis, the market is likely to achieve its pre-pandemic growth in the next two to three years.
In addition, the electrosurgical generator market is expected to grow due to the rise in chronic diseases and the geriatric population, increasing demands for minimally invasive surgeries, and technological advancements in electrosurgical units. For instance, according to the British Heart Foundation's 2022 report, approximately 7.6 million people in United Kingdom have heart and circulatory disorders. Moreover, with an aging and growing population, as well as underlying conditions affecting the heart and circulatory system, these numbers could keep rising. Electrosurgical generators play a vital role in cardiac surgeries, helping to cut the tissues and control bleeding. Thus, the increasing burden of heart-related disorders will, in turn, boost the demand for electrosurgical generators in healthcare settings over the coming years.
Furthermore, the new research studies on electrosurgical devices reveal the safety profile of the devices and help in the market's growth. For instance, as per the study report by Cristina Ibanez Jimenez in February 2022, SynchroSeal's multifunctional design with the E-100 electrosurgical generator provides enhanced sealing and transection capabilities with an acceptable safety profile. Thus, the new studies help the market by providing efficient and safe products and will drive the market over the forecast period. However, the risks associated with electrosurgical procedures and stringent regulatory frameworks are the major factors hindering market growth.
Electrosurgery is a procedure that uses an electric current to cut, remove, or destroy tissue and control bleeding. It is commonly used in various urologic surgeries, such as partial nephrectomy, pyeloplasty, adrenalectomy, radical prostatectomy, and cystectomy. With the increasing use of electrosurgical generators, the market segment for urology is expected to garner a substantial market share.
The rising cancer cases are also contributing to the segment's growth. For instance, as per the report published by the American Cancer Society in January 2022, an estimated 81,180 new cases of bladder cancer, with 61,700 in men and 19,480 in women, were registered in United States. This shows a high burden of the disease and increases the demand for the resection of the tumor. Cystectomy is a procedure in which the urinary bladder is removed surgically to treat bladder cancer.
Similarly, per the above source, prostate cancer is one of the most common cancers in American men. An estimated 268,490 new cases of prostate cancer were registered in 2022. Hence, the demand for cystectomy and prostatectomy using electrosurgical generators is expected to increase, which ultimately drives the market demand for generators in the urology segment.
Furthermore, in September 2021, Olympus launched its first devices in the new POWERSEAL family of advanced bipolar surgical energy products. The POWERSEAL devices can be used in numerous forms of surgical intervention, including urological surgical procedures. Hence with new product approvals and launches, the demand for electrosurgical generators is anticipated to observe significant growth over the forecast period.
The market for electrosurgical generators in North America is likely to be dominated by United States due to the region's sophisticated healthcare facilities and an advanced technology approach. The major factors, such as the increasing burden of chronic diseases like cancer and the growing geriatric population, along with technological advancements, are expected to fuel the market's growth.
For instance, the Canadian Cancer Society estimated 233,900 people in Canada to be diagnosed with cancer by the end of 2022, which is a high count compared to the 229,200 cases in 2021. The increase in cancer cases requires the resection of the tumors, which can be achieved using electrosurgical procedures and is thus expected to drive the market over the forecast period.
Furthermore, according to the Health Authorities in B.C. 2022, the surgical wait time for 90% of skin tumor removal cases in Canada is estimated at 15.2 weeks. Longer wait times for open surgeries will bolster the demand for minimally invasive surgeries such as electrosurgical procedures, boosting the demand for electrosurgical generators across healthcare facilities.
Moreover, the new product approvals and launches by the major market players are helping the market grow. For instance, in January 2022, Ethicon received United States FDA approval for the Megadyne Electrosurgical Generator. It is intended to be used as a general-purpose electrosurgical generator for a wide variety of open and laparoscopic procedures. Hence, the new approval of the electrosurgical generators in the region, in turn, increases the scope of the device towards multiple applications and helps the market to grow over the study period.
The electrosurgical generator market is moderately fragmented. The global key players are manufacturing the majority of the electrosurgical generators. Market leaders who have greater resources for research and a better distribution network have carved out a place for themselves in the industry. Some of the major players include Medtronic, CONMED Corporation, Johnson & Johnson Services, Inc. (Ethicon, Inc.), Olympus Corporation, B. Braun SE, Aspen Surgical (Symmetry Surgical Inc.), Medrange Corporation, Applied Medical Resources Corporation, KARL STORZ SE & Co. KG, BD (Becton, Dickinson, and Company), and US Medical Innovations.